Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439791/all/Disease‐modifying_treatments_for_primary_autoimmune_haemolytic_anaemia_New. Accessed 29 March 2024.
Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439791/all/Disease‐modifying_treatments_for_primary_autoimmune_haemolytic_anaemia_New. Accessed March 29, 2024.
Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439791/all/Disease‐modifying_treatments_for_primary_autoimmune_haemolytic_anaemia_New
Anti‐vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439791/all/Disease‐modifying_treatments_for_primary_autoimmune_haemolytic_anaemia_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
ID - 439791
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439791/all/Disease‐modifying_treatments_for_primary_autoimmune_haemolytic_anaemia_New
DB - Evidence Central
DP - Unbound Medicine
ER -